Article Listing - EUROPE STOCK COMMENT

GLAXO FRANCE CHIEF QUITS

6 April 1992

Edwin Nathan, president of Glaxo France and of the group's Belgian and Luxembourg companies, has announced his departure from the...

PROFITS UP AT ITALIAN SORIN BIOMEDICA IN 1991

6 April 1992

Sorin Biomedica made net profits in 1991 of 12.3 billion lire ($9.9 billion), up from 11 billion lire in the...

EPIC REGISTRATION NOW OVER 1,300

6 April 1992

Speaking at the 12th International Symposium on Intensive Care and Emergency Medicine in Brussels, late last month, Andre Heyns, Roussel-...

INTERFERON ALFA-N3 AND AIDS

6 April 1992

Researchers at the Walter Reed Army Institute of Research and at Interferon Sciences have commenced Phase I trials with the...

PA CONSULTING GROUP APPOINTMENTS

6 April 1992

Appointed as senior associates for the pharmaceutical industry at PA Consulting Group are Keith Mansford, former chairman of R&D...

NEW PRES AT RHONE-POULENC RORER

6 April 1992

Rhone-Poulenc Rorer Inc has named Manfred Karobath as senior vice president, RPR, and president, RPR Research and Development. He was...

MG FRANCE ATTACKS GOVT COST-CUTTING

6 April 1992

The association of doctors in France, MG France, has attacked the agreement on health care expenditures which has been...

INDIAN IBUPROFEN CHARGE DROPPED

6 April 1992

The US Department of Commerce has ceased its activities relating to claims of dumping and subsidies concerning imports into...

WALDEGRAVE GIVES MESSAGE TO UK PHARMA INDUSTY

6 April 1992

From UK Health Secretary William Waldegrave

As the UK's general election campaigning draws to a conclusion, Secretary of State for Health...

HUNGARIAN DRUGS "STILL COMPETITIVE"

6 April 1992

Despite the collapse of the Soviet market, Hungarian pharmaceutical companies have succeeded in making up for these lost sales by...